Quick answers
- What is Antara?
- Antara is a brand name of Fenofibrate, a prescription medicine. The FDA NDC Directory lists 4 Antara products in 4 strengths and forms.
- Who makes Antara?
- Lupin holds the FDA application for Antara (NDA021695, approved November 30, 2004).
- Is there a generic or store brand of Antara?
- Yes. The FDA NDC Directory lists 7 other products with the same active ingredients, strength and form as a Antara product, 7 of them generic. Ask your pharmacist whether one is right for you.
- Has Antara been recalled?
- No recall linked to Antara products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Antara is
Each Antara product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Fenofibrate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| fenofibrate 130 mg capsule (oral) | Antara | 4 products, 4 companies | DailyMed |
| fenofibrate 30 mg capsule (oral) | Antara | None listed | DailyMed |
| fenofibrate 43 mg capsule (oral) | Antara | 3 products, 3 companies | DailyMed |
| fenofibrate 90 mg capsule (oral) | Antara | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Fenofibrate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA021695 | Lupin | November 30, 2004 | 4 |
Companies that list Antara
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Antara products.
- Lupin Pharmaceuticals, Inc.4 products
Recalls
No recall linked to Antara products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.